Quick Summary
Hibiscus sabdariffa, commonly known as roselle, is a plant traditionally used for managing cardiovascular conditions such as hypertension and metabolic disorders. Clinical studies and systematic reviews provide evidence suggesting it may have beneficial effects on blood pressure, lipid profiles, glycemic control, and inflammation. While Hibiscus generally has a favorable safety profile with minimal reported adverse effects, methodological limitations and variability in studies indicate the need for further high-quality clinical trials to confirm these findings and clarify optimal dosing and duration.
What is it
Hibiscus sabdariffa is a flowering plant native to tropical regions, often recognized for its bright red calyces. It is used as an herbal tea, supplement, and in traditional medicine preparations worldwide, especially for cardiovascular and metabolic health support.
Traditional Uses
- Management of high blood pressure (hypertension)
- Support for cardiovascular health
- Alleviation of metabolic disorders including elevated blood lipids and blood sugar
- Symptomatic relief in urinary tract discomfort
Active Compounds
Hibiscus sabdariffa contains several bioactive compounds such as:
- Anthocyanins (pigments with antioxidant properties)
- Flavonoids
- Organic acids (e.g., hibiscus acid)
- Polysaccharides
- Vitamin C and other antioxidants
Potential Benefits with Evidence Levels
Blood Pressure Reduction
Multiple meta-analyses of randomized controlled trials indicate that Hibiscus sabdariffa may reduce systolic and diastolic blood pressure in adults with mild-to-moderate hypertension. Effects are comparable to some antihypertensive drugs but not superior. Benefits appear more pronounced in older adults, with treatment durations over four weeks and in studies with low risk of bias.
Evidence Level: Moderate certainty
Lipid Profile Modulation
Evidence from clinical reviews and meta-analyses suggests Hibiscus may improve lipid parameters by reducing total cholesterol, LDL cholesterol, and triglycerides, while increasing HDL cholesterol. These changes may potentially contribute to cardiovascular risk reduction.
Evidence Level: Low to moderate certainty
Glycemic Control
Some clinical studies report that Hibiscus is associated with reductions in fasting blood glucose and improved glycemic parameters, implying potential benefits in metabolic syndrome and type 2 diabetes management.
Evidence Level: Low to moderate certainty
Anti-Inflammatory and Antioxidant Effects
Hibiscus exhibits anti-inflammatory and antioxidative properties in both clinical and preclinical settings, including modulation of inflammatory markers and oxidative stress-related enzymes.
Evidence Level: Low to moderate certainty
Potential Benefit in Urinary Tract Infections
Some clinical evidence suggests Hibiscus, often combined with other agents, may aid in symptomatic relief and prevention of uncomplicated urinary tract infections. Evidence for Hibiscus as a sole treatment is insufficient.
Evidence Level: Insufficient clinical evidence for monotherapy
Obesity and Weight Management
Clinical trials have not demonstrated significant benefit of Hibiscus alone for weight loss or obesity treatment. Some metabolic improvements may occur when combined with exercise or other interventions.
Evidence Level: Low certainty; no demonstrable clinical benefit in weight loss
Side Effects
Hibiscus sabdariffa is generally well tolerated in clinical trials with few reported adverse effects. Minor increases in liver enzymes have been observed but were clinically insignificant. No consistent evidence indicates serious adverse events related to its use.
Drug Interactions
Possible interactions with antihypertensive medications and diuretics have been noted but are insufficiently studied. Caution is advised when consuming Hibiscus alongside conventional blood pressure medications due to potential additive effects. Further research is needed on herb-drug interactions.
Who Should Avoid It
- Individuals currently taking antihypertensive medications should exercise caution and consult healthcare providers prior to use
- Pregnant or breastfeeding individuals, due to insufficient safety data
- Those with known allergies or sensitivities to Hibiscus or related plants
Evidence Limitations
Many studies suffer from methodological heterogeneity, small sample sizes, variability in Hibiscus preparations, dosages, and short treatment durations. High risk of bias and inconsistent findings limit certainty. More high-quality, standardized, multicenter randomized controlled trials with sufficient power and longer durations are needed to confirm efficacy, determine optimal dosing, and assess long-term safety.
References
- Efficacy and safety of Hibiscus sabdariffa in cardiometabolic health: An overview of reviews and updated dose-response meta-analysis (PMID: 39870328)
- Efficacy of Hibiscus sabdariffa on Reducing Blood Pressure in Patients With Mild-to-Moderate Hypertension: A Systematic Review and Meta-Analysis (PMID: 34694241)
- A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers (PMID: 34927694)
- Therapeutic Potential of Hibiscus sabdariffa Linn. in Attenuating Cardiovascular Risk Factors (PMID: 37375755)
- Exploring the Health Benefits and Therapeutic Potential of Roselle (Hibiscus sabdariffa) in Human Studies: A Comprehensive Review (PMID: 38024072)
- Clinical effects of Hibiscus sabdariffa Linn. on obesity treatment: A systematic review and meta-analysis (PMID: 38878905)
- Xyloglucan, Hibiscus and Propolis in the Management of Uncomplicated Lower Urinary Tract Infections: A Systematic Review and Meta-Analysis (PMID: 35052890)
- Roselle for hypertension in adults (PMID: 34837382)
Last Reviewed
June 2024
Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Consult a healthcare professional before using Hibiscus sabdariffa or any other herbal supplement, especially if you have underlying health conditions or are taking prescription medications.